PuSH - Publikationsserver des Helmholtz Zentrums München

Gorski, M.* ; Rasheed, H.* ; Teumer, A.* ; Thomas, L.F.* ; Graham, S.E.* ; Sveinbjornsson, G.* ; Winkler, T.W.* ; Günther, F.* ; Stark, K.J.* ; Chai, J.F.* ; Tayo, B.O.* ; Wuttke, M.* ; Li, Y.* ; Tin, A.* ; Ahluwalia, T.S.* ; Ärnlöv, J.* ; Asvold, B.O.* ; Bakker, S.J.L.* ; Banas, B.* ; Bansal, N.* ; Biggs, M.L.* ; Biino, G.* ; Böhnke, M.* ; Boerwinkle, E.* ; Bottinger, E.P.* ; Brenner, H.* ; Brumpton, B.M.* ; Carroll, R.J.* ; Chaker, L.* ; Chalmers, J.* ; Chee, M.L.* ; Cheng, C.Y.* ; Chu, A.Y.* ; Ciullo, M.* ; Cocca, M.* ; Cook, J.P.* ; Coresh, J.* ; Cusi, D.* ; de Borst, M.H.* ; Degenhardt, F.* ; Eckardt, K.U.* ; Endlich, K.* ; Evans, M.K.* ; Feitosa, M.F.* ; Franke, A.* ; Freitag-Wolf, S.* ; Fuchsberger, C.* ; Gampawar, P.* ; Gansevoort, R.T.* ; Ghanbari, M.* ; Ghasemi, S.* ; Giedraitis, V.* ; Gieger, C. ; Gudbjartsson, D.F.* ; Hallan, S.* ; Hamet, P.* ; Hishida, A.* ; Ho, K.* ; Hofer, E.* ; Holleczek, B.* ; Holm, H.* ; Hoppmann, A.* ; Horn, K.* ; Hutri-Kähönen, N.* ; Hveem, K.* ; Hwang, S.J.* ; Ikram, M.A.* ; Josyula, N.S.* ; Jung, B.* ; Kähönen, M.* ; Karabegović, I.* ; Khor, C.C.* ; Koenig, W.* ; Kramer, H.* ; Krämer, B.K.* ; Kühnel, B. ; Kuusisto, J.* ; Laakso, M.* ; Lange, L.A.* ; Lehtimäki, T.* ; Li, M.* ; Lieb, W.* ; Lifelines Cohort Study* ; Lind, L.* ; Lindgren, C.M.* ; Loos, R.J.F.* ; Lukas, M.A.* ; Lyytikäinen, L.P.* ; Mahajan, A.* ; Matias-Garcia, P.R. ; Meisinger, C. ; Meitinger, T. ; Melander, O.* ; Milaneschi, Y.* ; Mishra, P.P.* ; Mononen, N.* ; Morris, A.P.* ; Mychaleckyj, J.C.* ; Nadkarni, G.N.* ; Naito, M.* ; Nakatochi, M.* ; Nalls, M.A.* ; Nauck, M.* ; Nikus, K.* ; Ning, B.* ; Nolte, I.M.* ; Nutile, T.* ; O'Donoghue, M.L.* ; O'Connell, J.* ; Olafsson, I.* ; Orho-Melander, M.* ; Parsa, A.* ; Pendergrass, S.A.* ; Penninx, B.W.J.H.* ; Pirastu, M.* ; Preuss, M.H.* ; Psaty, B.M.* ; Raffield, L.M.* ; Raitakari, O.T.* ; Rheinberger, M.* ; Rice, K.M.* ; Rizzi, F.* ; Rosenkranz, A.R.* ; Rossing, P.* ; Rotter, J.I.* ; Ruggiero, D.* ; Ryan, K.A.* ; Sabanayagam, C.* ; Salvi, E.* ; Schmidt, H.* ; Schmidt, R.* ; Scholz, M.* ; Schöttker, B.* ; Schulz, C.A.* ; Sedaghat, S.* ; Shaffer, C.M.* ; Sieber, K.B.* ; Sim, X.* ; Sims, M.* ; Snieder, H.* ; Stanzick, K.J.* ; Thorsteinsdottir, U.* ; Stocker, H.R.* ; Strauch, K. ; Stringham, H.M.* ; Sulem, P.* ; Szymczak, S.* ; Taylor, K.D.* ; Thio, C.H.L.* ; Tremblay, J.* ; Vaccargiu, S.* ; van der Harst, P.* ; van der Most, P.J.* ; Verweij, N.* ; Völker, U.* ; Wakai, K.* ; Waldenberger, M. ; Wallentin, L.* ; Wallner, S.* ; Wang, J.* ; Waterworth, D.M.* ; White, H.D.* ; Willer, C.J.* ; Wong, T.Y.* ; Woodward, M.* ; Yang, Q.* ; Yerges-Armstrong, L.M.* ; Zimmermann, M.* ; Zonderman, A.B.* ; Bergler, T.* ; Stefansson, K.* ; Böger, C.A.* ; Pattaro, C.* ; Köttgen, A.* ; Kronenberg, F.* ; Heid, I.M.*

Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies.

Kidney Int. 102, 624-639 (2022)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Estimated glomerular filtration rate (eGFR) reflects kidney function. Progressive eGFR-decline can lead to kidney failure, necessitating dialysis or transplantation. Hundreds of loci from genome-wide association studies (GWAS) for eGFR help explain population cross section variability. Since the contribution of these or other loci to eGFR-decline remains largely unknown, we derived GWAS for annual eGFR-decline and meta-analyzed 62 longitudinal studies with eGFR assessed twice over time in all 343,339 individuals and in high-risk groups. We also explored different covariate adjustment. Twelve genome-wide significant independent variants for eGFR-decline unadjusted or adjusted for eGFR-baseline (11 novel, one known for this phenotype), including nine variants robustly associated across models were identified. All loci for eGFR-decline were known for cross-sectional eGFR and thus distinguished a subgroup of eGFR loci. Seven of the nine variants showed variant-by-age interaction on eGFR cross section (further about 350,000 individuals), which linked genetic associations for eGFR-decline with age-dependency of genetic cross-section associations. Clinically important were two to four-fold greater genetic effects on eGFR-decline in high-risk subgroups. Five variants associated also with chronic kidney disease progression mapped to genes with functional in-silico evidence (UMOD, SPATA7, GALNTL5, TPPP). An unfavorable versus favorable nine-variant genetic profile showed increased risk odds ratios of 1.35 for kidney failure (95% confidence intervals 1.03-1.77) and 1.27 for acute kidney injury (95% confidence intervals 1.08-1.50) in over 2000 cases each, with matched controls). Thus, we provide a large data resource, genetic loci, and prioritized genes for kidney function decline, which help inform drug development pipelines revealing important insights into the age-dependency of kidney function genetics.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Acute Kidney Injury ; Chronic Kidney Disease ; Diabetes ; Gene Expression
ISSN (print) / ISBN 0085-2538
e-ISSN 1523-1755
Zeitschrift Kidney International
Quellenangaben Band: 102, Heft: 3, Seiten: 624-639 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology II (EPI2)
Independent Research Group Clinical Epidemiology (KEPI)
Institute of Human Genetics (IHG)
Institute of Genetic Epidemiology (IGE)
Förderungen UK Biobank
Deutsche Forschungsgemeinschaft DFG